{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:09:19Z","timestamp":1791346159151,"version":"4.3.1"},"update-to":[{"DOI":"10.1002\/14651858.cd004034.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2009,10,7]],"date-time":"2009-10-07T00:00:00Z","timestamp":1254873600000}}],"reference-count":96,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd004034.pub3","type":"journal-article","created":{"date-parts":[[2009,10,21]],"date-time":"2009-10-21T17:55:42Z","timestamp":1256147742000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":110,"title":["Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia"],"prefix":"10.1002","author":[{"given":"Bernadette","family":"McGuinness","sequence":"first","affiliation":[{"name":"Queen's University Belfast; Department of Geriatric Medicine; Whitla Medical Building 97 Lisburn Road Belfast UK BT9 7BL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Todd","sequence":"additional","affiliation":[{"name":"Queen's University Belfast; Department of Geriatric Medicine; Whitla Medical Building 97 Lisburn Road Belfast UK BT9 7BL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Passmore","sequence":"additional","affiliation":[{"name":"Queen's University Belfast; Department of Geriatric Medicine; Whitla Medical Building 97 Lisburn Road Belfast UK BT9 7BL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Bullock","sequence":"additional","affiliation":[{"name":"Kingshill Research Centre, Victoria Hospital; Okus Road Swindon UK SN4 4HZ"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,10,7]]},"reference":[{"key":"10.1002\/14651858.CD004034.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2165\/00002512-200118030-00001","article-title":"Hypertension in the Very Elderly Trial (HYVET): protocol for the main trial","volume":"18","author":"Bulpitt","year":"2001","journal-title":"Drugs & Aging"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2165\/00002512-200623010-00008","article-title":"A substudy protocol of the Hypertension in the Very Elderly Trial assessing cognitive decline and dementia incidence (HYVET-COG): an ongoing randomised, double-blind, placebo-controlled trial","volume":"23","author":"Peters","year":"2006","journal-title":"Drugs Aging"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1056\/NEJMoa0801369","article-title":"Treatment of hypertension in patients 80 years of age or older","volume":"358","author":"Beckett","year":"2008","journal-title":"NEJM"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S1474-4422(08)70143-1","article-title":"Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial","volume":"7","author":"Peters","year":"2008","journal-title":"Lancet Neurology"},{"issue":"4","key":"10.1002\/14651858.CD004034.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/sj.jhh.1001657","article-title":"Health-related quality of life during treatment of elderly patients with hypertension: results from the Study on COgnition and Prognosis in the Elderly (SCOPE)","volume":"18","author":"Degl'Innocenti","year":"2004","journal-title":"Journal of Human Hypertension"},{"issue":"8","key":"10.1002\/14651858.CD004034.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1097\/01.hjh.0000133730.47372.4c","article-title":"The Study of COgnition and Prognosis in the Elderly (SCOPE); outcomes in patients not receiving add-on therapy after randomization","volume":"22","author":"Lithell","year":"2004","journal-title":"Journal of Hypertension"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/00004872-200305000-00011","article-title":"The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomised double-blind intervention trial","volume":"21","author":"Lithell","year":"2003","journal-title":"Journal of Hypertension"},{"issue":"6","key":"10.1002\/14651858.CD004034.pub3-BIB0008|cit8","first-page":"1175","article-title":"Stroke Prevention With the Angiotension II Type-1 Receptor Blocker Candesartan in Elderly Patients With Isolated Systolic Hypertension. The Study on Cognition and Prognosis in the Elderly (SCOPE)","volume":"44","author":"Papademetriou","year":"2004","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0009|cit9","doi-asserted-by":"crossref","unstructured":"Skoog I Lithell H Hansson L Elmfeldt D Hofman A Olofsson B for the SCOPE Study Group Effect of baseline cognitive function and antihypertensive treatment on cognitive and cardiovascular outcomes: Study on COgnition and Prognosis in the Elderly (SCOPE) American Journal of Hypertension 2005 1052 1059","DOI":"10.1016\/j.amjhyper.2005.02.013"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1001\/archinte.1994.00420190047006","article-title":"Impact of the Treatment of Isolated Systolic Hypertension on Behavioral Variables. Results From the Systolic Hypertension in the Elderly Program","volume":"154","author":"Applegate","year":"1994","journal-title":"Arch Intern Med"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/aje\/153.1.72","article-title":"Dementia and Disability Outcomes in Large Hypertension Trials: Lessons Learned from the Systolic Hypertension in the Elderly Program (SHEP) Trial","volume":"153","author":"Bari","year":"2001","journal-title":"American Journal of Epidemiology"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1001\/jama.1991.03460240051027","article-title":"Prevention of Stroke by Antihypertensive Drug Treatment in Older Persons With Isolated Systolic Hypertension. Final Results of the Systolic Hypertension in the Elderly Program (SHEP)","volume":"265","author":"SHEP Cooperative Research Group","year":"1991","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/0895-4356(88)90024-8","article-title":"Rationale and Design of a Randomized Clinical Trial on Prevention of Stroke in Isolated Systolic Hypertension","volume":"41","author":"The Systolic Hypertension in the Elderly Program (SHEP) Cooperative Research Group","year":"1988","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF03324024","article-title":"Syst-Eur. A multicentre trial on the treatment of isolated systolic hypertension in the elderly: Objectives, protocol, and organization","volume":"3","author":"Amery","year":"1991","journal-title":"Aging Clin Exp Res"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1097\/00004872-200210000-00028","article-title":"Quality of life on randomised treatment for isolated hypertension: results from the Syst-Eur Trial","volume":"20","author":"Fletcher","year":"2002","journal-title":"Journal of Hypertension"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1097\/00004872-199816080-00006","article-title":"Quality of life of elderly patients with isolated systolic hypertension: baseline data from the Syst-Eur Trial","volume":"16","author":"Fletcher","year":"1988","journal-title":"Journal of Hypertension"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1001\/archinte.162.18.2046","article-title":"The Prevention of Dementia With Antihypertensive Treatment. New Evidence From the Systolic Hypertension in Europe (Syst-Eur) Study","volume":"162","author":"Forette","year":"2002","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0019|cit18","first-page":"D17","article-title":"Reduction of dementia by calcium-antagonist-based antihypertensive treatment","volume":"2","author":"Forette","year":"2000","journal-title":"European Heart Journal Supplements"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0018|cit19","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0140-6736(98)03086-4","article-title":"Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) Trial","volume":"352","author":"Forette","year":"1998","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(97)05381-6","article-title":"Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension","volume":"350","author":"Staessen","year":"1997","journal-title":"The Lancet"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1161\/01.HYP.0000086521.95630.5A","article-title":"Diuretic Versus Alpha-Blocker as First-Step Antihypertensive Therapy. Final Results From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)","volume":"42","author":"ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group","year":"2003","journal-title":"Hypertension"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(05)67185-1","article-title":"Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomized controlled trial","volume":"366","author":"Dahlof","year":"2005","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1161\/hy1101.095000","article-title":"One-Year Study of Felodipine or Placebo for Stage 1 Isolated Systolic Hypertension","volume":"38","author":"Black","year":"2001","journal-title":"Hypertension"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/oxfordjournals.aje.a116868","article-title":"Untreated Blood Pressure Level is Inversely Related to Cognitive Functioning: The Framingham Study","volume":"138","author":"Elias","year":"1993","journal-title":"American Journal of Epidemiology"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1093\/oxfordjournals.aje.a114749","article-title":"Blood Pressure and Cognitive Performance. The Framingham Study","volume":"126","author":"Farmer","year":"1987","journal-title":"American Journal of Epidemiology"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0140-6736(96)09328-2","article-title":"Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study","volume":"349","author":"Hofman","year":"1997","journal-title":"The Lancet"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","article-title":"Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial","volume":"351","author":"Hansson","year":"1998","journal-title":"The Lancet"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1016\/S0149-2918(03)80334-X","article-title":"Efficacy and Tolerability of Oral Stevioside in Patients with Mild Essential Hypertension: A Two-Year, Randomised, Placebo-Controlled Study","volume":"25","author":"Hsieh","year":"2003","journal-title":"Clinical Therapeutics"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1161\/01.HYP.31.3.780","article-title":"Hypertension is Related to Cognitive Impairment. A 20-Year Follow-up of 999 men","volume":"31","author":"Kilander","year":"1998","journal-title":"Hypertension"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/0002-9343(89)90142-3","article-title":"Effects of antihypertensive therapy on blood pressure control, cognition and reactivity. A placebo-controlled comparison of prazosin, propranolol, and hydrochlorothiazide","volume":"86","author":"Lasser","year":"1989","journal-title":"Am J Med"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1001\/jama.1995.03530230032026","article-title":"The Association Between Midlife Blood Pressure Levels and Late-Life Cognitive Function. The Honolulu-Asia Aging Study","volume":"274","author":"Launer","year":"1995","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/oxfordjournals.aje.a112185","article-title":"Epidemiologic Studies of Coronary Heart Disease and Stroke in Japanese Men Living in Japan, Hawaii and California: Introduction","volume":"102","author":"Syme","year":"1975","journal-title":"American Journal of Epidemiology"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0033|cit33","first-page":"40","article-title":"Does the Combination of ACE Inhibitor and Calcium Antagonist Control Hypertension and Improve Quality of Life? The LOMIR-MCT-IL Study Experience","volume":"3(Suppl 1)","author":"Amir","year":"1994","journal-title":"Blood Pressure"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"62S","DOI":"10.1093\/ajh\/6.3.62S","article-title":"Reexamining the Quality of Life of Hypertensive Patients. A New Self-Structured Measure","volume":"6","author":"Bar-On","year":"1993","journal-title":"American Journal of Hypertension"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"57S","DOI":"10.1093\/ajh\/6.3.57S","article-title":"A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of Isradipine and Methyldopa as Monotherapy or in Combination With Captopril in the Treatment of Hypertension","volume":"6","author":"Yodfat","year":"1993","journal-title":"American Journal of Hypertension"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.304.6824.405","article-title":"Medical Research Council trial of treatment of hypertension in older adults: principal results","volume":"304","author":"MRC W orking Party","year":"1992","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0037|cit37","first-page":"616","article-title":"Results of MRC (UK) trial of drug therapy for mild hypertension","volume":"10","author":"Peart","year":"1987","journal-title":"Clin Invest Med"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1017\/S0033291700035637","article-title":"A longitudinal study of factors predicting change in cognitive test scores over time, in an older hypertensive population","volume":"26","author":"Prince","year":"1996","journal-title":"Psychological Medicine"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1136\/bmj.312.7034.801","article-title":"Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council's treatment trial of hypertension in older adults","volume":"312","author":"Prince","year":"1996","journal-title":"BMJ"},{"issue":"18","key":"10.1002\/14651858.CD004034.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1001\/archinte.162.18.2090","article-title":"Preservation of Cognitive Function With Antihypertensive Medications: A Longitudinal Analysis of a Community-Based Sample of African Americans Preservation of Cognitive Function With Antihypertensive Medications: A Longitudinal Analysis of a Community-Based Sample of African Americans","volume":"162","author":"Murray","year":"2002","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/archinte.163.9.1069","article-title":"Effects of Blood Pressure Lowering With Perindopril and Indapamide Therapy on Dementia and Cognitive Decline in Patients With Cerebrovascular Disease","volume":"163","author":"The PROGRESS Collaborative Group","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1111\/j.1532-5415.2000.tb04777.x","article-title":"The Association Between Vascular Risk Factor-Mediating Medications and Cognition and Dementia Diagnosis in a Community-Based Sample of African-Americans","volume":"48","author":"Richards","year":"2000","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0140-6736(96)90608-X","article-title":"15-year longitudinal study of blood pressure and dementia","volume":"347","author":"Skoog","year":"1996","journal-title":"The Lancet"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1532-5415.1996.tb06412.x","article-title":"The Effects of Antihypertensive Treatment on Cognitive Function: Results from the HOPE Study","volume":"44","author":"Starr","year":"1996","journal-title":"Journal of the American Geriatric Society"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/0140-6736(91)92589-T","article-title":"Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP Hypertension)","volume":"338","author":"Dahlof","year":"1991","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1097\/00004872-199816120-00016","article-title":"Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension","volume":"16","author":"Liu","year":"1998","journal-title":"Journal of Hypertension"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/S0140-6736(04)16451-9","article-title":"Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial","volume":"363","author":"Julius","year":"2004","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0048|cit48","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1987"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0049|cit49","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1994"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1097\/01.hjh.0000244934.81180.16","article-title":"The effects of blood pressure reduction on cognitive function: a review of effects based on pooled data from clinic al trials","volume":"24","author":"Birns","year":"2006","journal-title":"Journal of Hypertension"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000017043","article-title":"Vascular risk s and incident dementia :results from a cohort study of the very old","volume":"9","author":"Brayne","year":"1998","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1056\/NEJM198312013092204","article-title":"Bias in Treatment Assignment in Controlled Clinical Trials","volume":"309","author":"Chalmers","year":"1983","journal-title":"N Eng J Med"},{"issue":"4","key":"10.1002\/14651858.CD004034.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/sj.jhh.1001657","article-title":"Health-related quality of life during treatment of elderly patients with hypertension: results from the Study on COgnition and Prognosis in the Elderly (SCOPE)","volume":"18","author":"Degl'Innocenti","year":"2004","journal-title":"Journal of Human Hypertension"},{"issue":"1","key":"10.1002\/14651858.CD004034.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/aje\/153.1.72","article-title":"Dementia and disability outcomes in large hypertension trials: lessons learned from the systolic hypertension in the elderly program (SHEP) trial","volume":"153","author":"Bari","year":"2001","journal-title":"American Journal of Epidemiology"},{"issue":"6","key":"10.1002\/14651858.CD004034.pub3-BIB0055|cit55","first-page":"352","article-title":"Untreated blood pressure is inversely related to cognitive functioning: the Framingham Study","volume":"138","author":"Elias","year":"1993","journal-title":"Journal of Epidemiology"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1161\/01.HYP.0000145858.07252.99","article-title":"Blood pressure related cognitive decline: does age make a difference?","volume":"44","author":"Elias","year":"2004","journal-title":"Hypertension"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jns.2004.11.020","article-title":"Does blood pressure lowering treatment prevent deme ntia or cognitive decline in patients with cardiovascular and cerebrovascular disease?","volume":"229","author":"Feigin","year":"2005","journal-title":"Journal of the N eurological Sciences"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00228-003-0717-9","article-title":"Effects of valsartan compared with enalapril on blood pressure and cognitive function in elderly patients with essential hypertension","volume":"59","author":"Fogari","year":"2004","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1001\/archinte.162.18.2046","article-title":"The Prevention of Dementia With Antihypertensive Treatment. New Evidence From the Systolic Hypertension in Europe (Syst-Eur) Study","volume":"162","author":"Forette","year":"2002","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1136\/bmj.312.7034.805","article-title":"Low blood pressure and dementia in elderly people : the Kungsholmen project","volume":"312","author":"Guo","year":"1996","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/archneur.56.8.991","article-title":"Occurence and progression of dementia in a community population aged 75 years and older: relationship of antihypertensive medication use","volume":"56","author":"Guo","year":"1999","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"2021-202 4","DOI":"10.1212\/01.WNL.0000129258.93137.4B","article-title":"Blood pressure and late-life cognitive function change: a biracial longitudinal population study","volume":"62","author":"Hebert","year":"2004","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0197-4580(00)00241-4","article-title":"Antihypertensive drugs and incidence of dementia: the Rotterdam Study","volume":"22","author":"in't Veld","year":"2001","journal-title":"Neurobiology of Aging"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.arr.2008.11.001","article-title":"Blood pressure and the risk for dementia - a d ouble edged sword","volume":"8","author":"Kennelly","year":"2009","journal-title":"Ageing Research Reviews"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1001\/archneur.63.5.noc60013","article-title":"Antihypertensive medic ation use and incident Alzheimer disease: the Cache County Study","volume":"63","author":"Khachaturian","year":"2006","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/ageing\/29.3.243","article-title":"The association b etween low diastolic blood pressure in middle age and cognitive function in old age: a population based study","volume":"29","author":"Kilander","year":"2000","journal-title":"Age Ageing"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1136\/bmj.322.7300.1447","article-title":"Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study","volume":"322","author":"Kivipelto","year":"2001","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0197-4580(00)00096-8","article-title":"Midlife blood pressure and dementia: the Honolulu-Asia aging study","volume":"21","author":"Launer","year":"2000","journal-title":"N eurobiology of Aging"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/aje\/kwf074","article-title":"Risk factors for Alzheimer's disease: a prospe ctive analysis from the Canadian Study of Health and Aging","volume":"156","author":"Lindsay","year":"2002","journal-title":"American Journal of Epidemiology"},{"issue":"8","key":"10.1002\/14651858.CD004034.pub3-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1097\/01.hjh.0000133730.47372.4c","article-title":"The Study of COgnition and Prognosis in the Elderly (SCOPE); outcomes in patients not receiving add-on therapy after randomization","volume":"22","author":"Lithell","year":"2004","journal-title":"Journal of Hypertension"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical Diagnosis of Alzheimer\u2019s Disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease","volume":"4","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1001\/archneur.58.10.1640","article-title":"Association of incident Alzheimer disease and blood pressure measured from 13 years before to 2 years after diagnosis in a large community study","volume":"58","author":"Morris","year":"2001","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0073|cit73","volume-title":"Cochrane Collaboration Handbook, The Cochrane Library [database on disc and CDROM ]","volume":"Issue 1","author":"Mulrow","year":"1997"},{"issue":"6","key":"10.1002\/14651858.CD004034.pub3-BIB0074|cit74","first-page":"1175","article-title":"Stroke Prevention With the Angiotension II Type-1 Receptor Blocker Candesartan in Elderly Patients With Isolated Systolic Hypertension. The Study on Cognition and Prognosis in the Elderly (SCOPE)","volume":"44","author":"Papademetriou","year":"2004","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S1474-4422(08)70143-1","article-title":"Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial","volume":"7","author":"Peters","year":"2008","journal-title":"Lancet Neurology"},{"issue":"3","key":"10.1002\/14651858.CD004034.pub3-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1017\/S0033291700035637","article-title":"A longitudinal study of factors predicting change in cognitive test scores over time, in an older hypertensive population","volume":"26","author":"Prince","year":"1996","journal-title":"Psychological Medicine"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1136\/bmj.312.7034.801","article-title":"Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council's treatment trial of hypertension in older adults","volume":"312","author":"Prince","year":"1996","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/archneur.60.2.223","article-title":"Low blood pressure and risk of dementia in the Kungsholmen project : a 6-year follow-up study","volume":"60","author":"Qiu","year":"2003","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1212\/WNL.61.5.655","article-title":"Combined effects of APOE genotype, blood pressure and antihypertensive drug use on incident AD","volume":"61","author":"Qiu","year":"2003","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1161\/01.STR.0000133128.42462.ef","article-title":"Decline in blood pressure over time and risk of dementia: a longitudi nal study from the Kungsholmen Project","volume":"35","author":"Qiu","year":"2004","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S1474-4422(05)70141-1","article-title":"The age-dependent relation of blood pressure to cognitive function and dementia","volume":"4","author":"Qui","year":"2005","journal-title":"Lancet Neurology"},{"issue":"2 Art. No.: CD0","key":"10.1002\/14651858.CD004034.pub3-BIB0082|cit82","doi-asserted-by":"publisher","DOI":"10.1002\/14651858","article-title":"Blood pressure lowering interventions for preventing dementia in patients with cerebrovascular disease (Protocol)","author":"Ratnasabapathy","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000051233","article-title":"Blood pressure and risk of dementia: results from the Rotterdam Study and the Gothenburg H-70 S tudy","volume":"12","author":"Ruitenberg","year":"2001","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/14651858.CD004034.pub3-BIB0085|cit85","first-page":"S31","article-title":"Senile hypertension and cognitive impairment: an overview","volume":"10","author":"Starr","year":"1992","journal-title":"Journal of Hypertension"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1212\/WNL.51.4.986","article-title":"Associa tion of midlife blood pressure to late-life cognitive decline and brain morphology","volume":"51","author":"Swan","year":"1998","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1159\/000076356","article-title":"Incidence and risk factors for mild cognitive impairment: a population based three-year follow-up study of cognitively healthy elderly subjects","volume":"17","author":"Tervo","year":"2004","journal-title":"Dementia and Geriatric Cognitive Dis orders"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1212\/01.WNL.0000098934.18300.BE","article-title":"Low blood pressure and the risk of dementia in very old individuals","volume":"61","author":"Verghese","year":"2003","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1053\/j.scds.2003.00.025","article-title":"Antihypertensive treatment and prevention of stroke and dementia","volume":"3","author":"Wang","year":"2003","journal-title":"Seminars in Cerebrovascular Diseases and Stroke"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1212\/01.WNL.0000149519.47454.F2","article-title":"Midlife cardiovascular risk factors and risk of dementia in late life","volume":"64","author":"Whitmer","year":"2005","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0091|cit91","volume-title":"The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines","author":"World Health Organisation","year":"1992"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/S0024-3205(02)02367-6","article-title":"Relationship between blood pressure and Alzheimer's disease in Linxian county","volume":"72","author":"Wu","year":"2003","journal-title":"Life Science"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1046\/j.1532-5415.2003.51117.x","article-title":"Association between dementia and midlife risk factors: the radiation effects research foundation adult health study","volume":"51","author":"Yamada","year":"2003","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.neurobiolaging.2004.03.009","article-title":"Calcium channel blockers and risk of AD: the Baltimore Longitudinal Study of Aging","volume":"26","author":"Yasar","year":"2005","journal-title":"Neurobiology of Aging"},{"key":"10.1002\/14651858.CD004034.pub3-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1212\/WNL.45.6.1161","article-title":"Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese study: the Hisayama Study","volume":"45","author":"Yoshitake","year":"1995","journal-title":"Neurology"},{"issue":"2","key":"10.1002\/14651858.CD004034.pub3-BIB0096|cit96","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004034.pub2","article-title":"Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia","author":"McGuinness","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd004034.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T00:00:00Z","timestamp":1621814400000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD004034.pub3\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T21:29:22Z","timestamp":1628544562000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD004034.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Dementia and Cognitive Improvement Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2009,10,7]]},"references-count":96,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004034.pub3","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD004034.pub4","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,7]]}}}